Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 4/2008

01-04-2008 | Alimmentary Tract

Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study

Authors: Yasumasa Niwa, Masanao Nakamura, Naoki Ohmiya, Osamu Maeda, Takafumi Ando, Akihiro Itoh, Yoshiki Hirooka, Hidemi Goto

Published in: Journal of Gastroenterology | Issue 4/2008

Login to get access
Metadata
Title
Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study
Authors
Yasumasa Niwa
Masanao Nakamura
Naoki Ohmiya
Osamu Maeda
Takafumi Ando
Akihiro Itoh
Yoshiki Hirooka
Hidemi Goto
Publication date
01-04-2008
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 4/2008
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-007-2155-4

Other articles of this Issue 4/2008

Journal of Gastroenterology 4/2008 Go to the issue

Liver, Pancreas, and Biliary Tract

Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells

Liver, Pancreas, and Biliary Tract

Amylase levels in bile in patients with a morphologically normal pancreaticobiliary ductal arrangement

Alimmentary Tract

Optical diagnosis of gastric cancer using near-infrared multichannel Raman spectroscopy with a 1064-nm excitation wavelength

Letters to the Editor

Reply to “High-sensitivity C-reactive protein and metabolic syndrome (insulin resistance syndrome) including nonalcoholic steatohepatitis”

Alimmentary Tract

Bleeding and stenosis caused by reflux esophagitis was not common in emergency endoscopic examinations: a retrospective patient chart review at a single institution in Japan

Alimmentary Tract

Evaluation of the depth score of type V pit patterns in crypt orifices of colorectal neoplastic lesions
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits